Inst Diagnosti (INDISA) — Cash Flow Reinvestment Rate
Inst Diagnosti (INDISA) has a Cash Flow Reinvestment Rate of 0.21x as of June 2023, reinvesting CL$1.89 Billion (capex CL$1.74 Billion plus investments CL$144.58 Million) from operating cash flow of CL$8.87 Billion. See cash generation quality of Inst Diagnosti to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Inst Diagnosti Cash Flow Reinvestment Rate (2014–2021)
Historical reinvestment intensity for Inst Diagnosti across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Inst Diagnosti.
Annual Cash Flow Reinvestment Rate for Inst Diagnosti (2014–2021)
Year-by-year capital reinvestment analysis for Inst Diagnosti. See INDISA financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CLP) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 4.33x | CL$64.16 Billion | CL$14.83 Billion | CL$31.45 Billion | ▲ +146.8% |
| 2020 | 1.75x | CL$25.34 Billion | CL$14.46 Billion | CL$12.45 Billion | ▲ +37.9% |
| 2019 | 1.27x | CL$13.55 Billion | CL$10.66 Billion | CL$7.44 Billion | ▲ +104.9% |
| 2018 | 0.62x | CL$9.15 Billion | CL$14.75 Billion | CL$4.72 Billion | ▼ -29.3% |
| 2017 | 0.88x | CL$13.06 Billion | CL$14.89 Billion | CL$8.63 Billion | ▼ -45.5% |
| 2016 | 1.61x | CL$18.62 Billion | CL$11.57 Billion | CL$9.73 Billion | ▲ +49.7% |
| 2015 | 1.08x | CL$16.19 Billion | CL$15.05 Billion | CL$12.30 Billion | ▲ +47.2% |
| 2014 | 0.73x | CL$9.92 Billion | CL$13.58 Billion | CL$6.03 Billion | — |